Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Archives of Cardiovascular Diseases Supplements ; 13(1):1-2, 2021.
Article in French | EMBASE | ID: covidwho-1333152

ABSTRACT

The proceedings contains 344 papers. The topics discussed include: Chronic coronary syndrome patients with polyarterial disease are a high risk but heterogenous subset of patients. Insights from the CLARIFY registry;Additional prognostic value of vasodilator stress cardiovascular magnetic resonance in patients with inconclusive stress test to detect coronary artery disease;Applicability of the REDUCE-IT trial to the FAST-MI registry. Are the results of randomized trials relevant in routine clinical practice?;Medical therapy at discharge in patients admitted for acute coronary syndrome: Data of the French MONICA population registers;Post-infectious myocardial Infarction: Does percutaneous coronary intervention improve outcomes? A propensity-score matched analysis;Prevalence and prognosis of iron deficiency in acute myocardial infarction;Myocardial infarction rates overview during COVID-19 pandemic In France: Results of the MODIF registry;Short-term air pollution concentration variations and ST-elevation myocardial infarction: A case-crossover study from the SCALIM registry;Predictive value of early cardiac mri functional and geometric indexes on adverse left ventricular remodelling in anterior STEMI patients. A report from the CIRCUS study;High levels of lipoprotein(a) are associated with the severity of coronary disease in patients with acute myocardial infarction. Data from the RICO survey;More than 30% of symptomatic patients at one year in “infarct like” acute myocarditis;Impact of use stent with a polyethylene terephthalate micro-net covering on coronary microvascular dysfunction in patients with acute myocardial infarction;Impact of Covid-19 infection in high-risk coronary patients;Coronary artery lesions in Kawasaki Disease;Activity of a catheterization laboratory in Tunisia: A comparative study before and during confinement (COVID-19);Acute coronary syndromes in the era of SARS-CoV-2 Infection: A registry of the French group of acute cardiac care

2.
Lancet Public Health ; 5(10): e536-e542, 2020 10.
Article in English | MEDLINE | ID: covidwho-779860

ABSTRACT

BACKGROUND: The COVID-19 pandemic has had a profound effect on general health care. We aimed to evaluate the effect of a nationwide lockdown in France on admissions to hospital for acute myocardial infarction, by patient characteristics and regional prevalence of the pandemic. METHODS: In this registry study, we collected data from 21 centres participating in the ongoing French Cohort of Myocardial Infarction Evaluation (FRENCHIE) registry, which collects data from all patients admitted for ST segment elevation myocardial infarction (STEMI) or non-ST segment elevation myocardial infarction (NSTEMI) within 48 h of symptom onset. We analysed weekly hospital admissions over 8 weeks: the 4 weeks preceding the institution of the lockdown and the 4 weeks following lockdown. The primary outcome was the change in the number of hospital admissions for all types of acute myocardial infarction, NSTEMI, and STEMI between the 4 weeks before lockdown and the 4 weeks after lockdown. Comparisons between categorical variables were made using χ2 tests or Fisher's exact tests. Comparisons of continuous variables were made using Student's t tests or Mann-Whitney tests. Poisson regression was used to determine the significance of change in hospital admissions over the two periods, after verifying the absence of overdispersion. Age category, region, and type of acute myocardial infarction (STEMI or NSTEMI) were used as covariables. The FRENCHIE cohort is registered with ClinicalTrials.gov, NCT04050956. FINDINGS: Between Feb 17 and April 12, 2020, 1167 patients were consecutively admitted within 48 h of acute myocardial infarction (583 with STEMI, 584 with NSTEMI) and were included in the study. Admissions for acute myocardial infarction decreased between the periods before and after lockdown was instituted, from 686 before to 481 after lockdown (30% decrease; incidence rate ratio 0·69 [95% CI 0·51-0·70]). Admissions for STEMI decreased from 331 to 252 (24%; 0·72 [0·62-0·85]), and admissions for NSTEMI decreased from 355 to 229 (35%; 0·64 [0·55-0·76]) following institution of the lockdown, with similar trends according to sex, risk factors, and regional prevalence of hospital admissions for COVID-19. INTERPRETATION: A marked decrease in hospital admissions was observed following the lockdown, irrespective of patient characteristics and regional prevalence of COVID-19. Health authorities should be aware of these findings, in order to adapt their message if the COVID-19 pandemic persists or recurs, or in case of future major epidemics. FUNDING: Recherche Hospitalo-Universitaire en Santé iVasc.


Subject(s)
Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Myocardial Infarction/therapy , Pandemics/prevention & control , Patient Admission/statistics & numerical data , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Aged , Aged, 80 and over , COVID-19 , Cohort Studies , Female , France/epidemiology , Humans , Male , Middle Aged , Prevalence , Registries , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL